Lucid Diagnostics reported a quarterly loss of $0.10 per share versus the Zacks consensus loss of $0.07, missing by $0.03. The loss narrowed from $0.19 a year ago, indicating year-over-year improvement despite the consensus miss.
Lucid Diagnostics reported a quarterly loss of $0.10 per share versus the Zacks consensus loss of $0.07, missing by $0.03. The loss narrowed from $0.19 a year ago, indicating year-over-year improvement despite the consensus miss.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
